Coronavirus HKU 1 infection with bronchiolitis, pericardial effusion and acute respiratory failure in obese adult female

J Asthma. 2021 Aug;58(8):1128-1131. doi: 10.1080/02770903.2020.1761981. Epub 2020 May 4.

Abstract

Seven species of coronavirus cause acute respiratory illness in humans. Coronavirus HKU 1 (CoV HKU 1) was first described in 2005 in an adult patient with pneumonia in Hong Kong. Although it is a well-known respiratory tract pathogen, there is not much information about its role in hospitalized adults, especially in southern Europe. Here, we describe a case of radiologically demonstrated CoV HKU 1-related bronchiolitis with acute respiratory failure in an adult female without significant comorbidities except obesity.

Keywords: Coronavirus; acute respiratory failure; bronchiolitis; virus infection.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Bronchiolitis / etiology*
  • Bronchiolitis / therapy
  • Bronchodilator Agents / therapeutic use
  • Ceftriaxone / therapeutic use
  • Coronavirus Infections / complications*
  • Coronavirus Infections / therapy
  • Coronavirus*
  • Female
  • Humans
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Obesity, Morbid / therapy
  • Oxygen / therapeutic use
  • Pericardial Effusion / etiology*
  • Pericardial Effusion / therapy
  • Respiratory Insufficiency / etiology*
  • Respiratory Insufficiency / therapy

Substances

  • Anti-Bacterial Agents
  • Bronchodilator Agents
  • Ceftriaxone
  • Oxygen
  • Methylprednisolone